
Investigators use a surrogate zzso when the zzso of interest is too difficult and/or expensive to measure routinely and when they can define some other, more readily zzso zzso that is sufficiently well correlated with the first to justify its use as a zzso A surrogate zzso is usually proposed on the basis of a zzso zzso In cancer studies with survival time as the primary zzso surrogate zzso frequently employed are zzso response, time to zzso or time to reappearance of disease, since these events occur earlier and are unaffected by use of secondary zzso In early drug development studies, zzso response is often the true primary zzso We discuss the investigation of the zzso of zzso zzso (a zzso marker present in the zzso as a surrogate for zzso zzso In considering the zzso of surrogate zzso one must distinguish between study zzso that provide a basis for reliable comparisons of therapeutic effect, and clinical zzso that are useful for patient management but have insufficient sensitivity and/or specificity to provide zzso assessments of the effects of particular zzso 

